Shanghai Pharmaceuticals Holding Co Ltd (601607) – Strategy, SWOT and Corporate Finance Report
- Pages: 46
- Published: June 2023
- Report Code: MLPH81212FSA
Shanghai Pharmaceuticals Holding Co Ltd (601607) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Shanghai Pharmaceuticals Holding Co Ltd (Shanghai Pharma) manufactures, markets, and distributes healthcare products. The company produces pharmaceutical products for the treatment of diarrhea, jaundice, fever, iron deficiency anemia, pancreatitis, coronary heart disease, lupus erythematosus, leprosy, acute myocardial infarction, and other diseases. It offers medicines for diseases and disorders of the cardiovascular system, digestive and metabolic system, neurological system, musculoskeletal system, and respiratory system. Shanghai Pharma also provides traditional Chinese medicines. It provides retail, distribution, and supply chain solutions to pharmaceutical manufacturers and dispensers; and operates retail and chain pharmacies. The company operates in China through its subsidiaries. Shanghai Pharma is headquartered in Shanghai, China.
Scope
• Detailed information on Shanghai Pharmaceuticals Holding Co Ltd required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Shanghai Pharmaceuticals Holding Co Ltd in the form of a SWOT analysis
• An in-depth view of the business model of Shanghai Pharmaceuticals Holding Co Ltd including a breakdown and examination of key business segments
• News about Shanghai Pharmaceuticals Holding Co Ltd, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Shanghai Pharmaceuticals Holding Co Ltd and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Shanghai Pharmaceuticals Holding Co Ltd as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Shanghai Pharmaceuticals Holding Co Ltds business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Simcere Pharmaceutical Group Ltd
Shenzhen Salubris Pharmaceuticals Co Ltd
Elion Energy Co Ltd
China National Accord Medicines Corporation Ltd
Harbin Pharmaceutical Group Holding Co Ltd
Sihuan Pharmaceutical Co Ltd
Tasly Pharmaceutical Group Co Ltd
Sihuan Pharmaceutical Holdings Group Ltd
Sinochem Hebei Corp
Nanjing Pharmaceutical Co Ltd
Tasly Pharmaceutical Group Co Ltd
Sihuan Pharmaceutical Holdings Group Ltd
Sinochem Hebei Corp
Elion Energy Co Ltd
Sihuan Pharmaceutical Co Ltd
Harbin Pharmaceutical Group Holding Co Ltd
Simcere Pharmaceutical Group Ltd
Shenzhen Salubris Pharmaceuticals Co Ltd
China National Accord Medicines Corporation Ltd
Nanjing Pharmaceutical Co Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.